Sort
261,768 grants matching “gene therapy”
Pacritinib in rel/refr T-cell lymphomas
$1,084,365Ryan A Wilcox · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Pre-clinical Bruker Albira Si PET/SPECT/CT imaging system
$1,084,326Jason Thanh Lee · Stanford University · S10 · FY2023 · OD
Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity
$1,084,321Anthony Schmitt · Arima Genomics, Inc. · R44 · FY2024 · GM
Studies of Natural SIV Infection of Sooty Mangabeys
$1,084,275Guido Silvestri · University Of Pennsylvania · R01 · FY2009 · AI
Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic
$1,084,194John Ramunas · Rejuvenation Technologies, Inc. · R44 · FY2024 · TR
RNAi and Epigenetic Control of Higher-Order Chromatin Assembly
$1,084,186Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
A "Trojan Horse" bispecific antibody strategy for broad filovirus therapeutics
$1,084,177Kartik Chandran · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Project 3: Characterization of the biology of non-responders using Imaging and molecular analysis to inform treatment
$1,084,062Laura J Van't Veer · University Of California, San Francisco · P01 · FY2024 · CA
TARGETING PCD FOR CANCER THERAPY
$1,084,031University Of Michigan At Ann Arbor · P01 · FY2002 · CA
Defining the resistome in P. falciparum: evolution and mechanism
$1,083,911Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2023 · AI
Growth Regulation and Therapy of Leukemias and Lymphomas
$1,083,899University Of Kentucky · P01 · FY2003 · CA
Influence of Task Complexity and Sensory Feedback on Cortical Control of Grasp Force
$1,083,874Jennifer L. Collinger · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · NS
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
$1,083,797Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE
$1,083,730Thomas Meek · Texas A&M Agrilife Research · R01 · FY2017 · AI
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,083,717Claire F Verschraegen · Ohio State University · UG1 · FY2022 · CA
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$1,083,650Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Xenobiotic receptors
$1,083,650Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
New targets against tuberculosis
$1,083,404Deborah T Hung · Broad Institute, Inc. · R01 · FY2019 · AI
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS
$1,083,387Jay Rappaport · Temple Univ Of The Commonwealth · P01 · FY2016 · MH
Assessment, Therapy and Prevention Of Autoimmune Disease
$1,083,181Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Conserved Element DNA Vaccine
$1,083,056Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
TULANE NATINAL PRIMATE RESEARCH CENTER
$1,082,820Paul K Whelton · Tulane University Of Louisiana · P51 · FY2006 · RR
MOUSE MODELS OF MYELOID LEUKEMIA
$1,082,737University Of California San Francisco · U01 · FY2002 · CA
PHARMACOTHERAPY DOSING REGIMEN
$1,082,617John G Grabowski · University Of Texas Hlth Sci Ctr Houston · P50 · FY2007 · DA
Discovery of antiviral agents targeting dengue viral translation
$1,082,325Joseph Matthew Colacino · Ptc Therapeutics, Inc. · R56 · FY2012 · AI